Inspire Medical Systems (NYSE:INSP) Trading 6.6% Higher – What’s Next?

Inspire Medical Systems, Inc. (NYSE:INSP)’s share price traded up 6.6% on Monday . The company traded as high as $42.32 and last traded at $42.6960. 63,037 shares were traded during mid-day trading, a decline of 95% from the average session volume of 1,229,793 shares. The stock had previously closed at $40.05.

Wall Street Analyst Weigh In

INSP has been the subject of several recent research reports. Wells Fargo & Company dropped their price target on Inspire Medical Systems from $70.00 to $56.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 5th. Robert W. Baird dropped their target price on Inspire Medical Systems from $63.00 to $50.00 and set a “neutral” rating for the company in a report on Tuesday, May 5th. Stifel Nicolaus decreased their price target on Inspire Medical Systems from $70.00 to $65.00 and set a “buy” rating on the stock in a report on Tuesday, May 5th. Piper Sandler downgraded Inspire Medical Systems from an “overweight” rating to a “neutral” rating and lowered their price target for the stock from $85.00 to $55.00 in a research report on Tuesday, May 5th. Finally, Truist Financial cut their price objective on shares of Inspire Medical Systems from $64.00 to $50.00 and set a “hold” rating on the stock in a research report on Tuesday, May 5th. Four analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, Inspire Medical Systems presently has a consensus rating of “Hold” and an average price target of $85.00.

Inspire Medical Systems Price Performance

The stock has a market capitalization of $1.20 billion, a PE ratio of 9.30, a P/E/G ratio of 4.14 and a beta of 0.83. The firm has a fifty day moving average price of $53.40 and a two-hundred day moving average price of $77.39.

Inspire Medical Systems (NYSE:INSP) last announced its quarterly earnings data on Monday, May 4th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of ($0.28) by $0.38. Inspire Medical Systems had a return on equity of 10.35% and a net margin of 14.33%.The company had revenue of $204.58 million for the quarter, compared to the consensus estimate of $200.04 million. During the same quarter in the prior year, the company posted $0.10 EPS. Inspire Medical Systems’s quarterly revenue was up 1.6% on a year-over-year basis. Inspire Medical Systems has set its FY 2026 guidance at 0.750-1.250 EPS. On average, research analysts expect that Inspire Medical Systems, Inc. will post 0.91 earnings per share for the current fiscal year.

Institutional Trading of Inspire Medical Systems

Large investors have recently modified their holdings of the company. Empowered Funds LLC purchased a new position in Inspire Medical Systems during the 1st quarter worth $1,799,000. Quantinno Capital Management LP lifted its holdings in shares of Inspire Medical Systems by 103.5% in the 1st quarter. Quantinno Capital Management LP now owns 26,555 shares of the company’s stock worth $1,370,000 after buying an additional 13,507 shares during the period. OMERS ADMINISTRATION Corp grew its position in shares of Inspire Medical Systems by 11.0% during the 1st quarter. OMERS ADMINISTRATION Corp now owns 16,153 shares of the company’s stock worth $833,000 after buying an additional 1,600 shares in the last quarter. Renaissance Technologies LLC increased its stake in shares of Inspire Medical Systems by 14.4% during the first quarter. Renaissance Technologies LLC now owns 469,968 shares of the company’s stock valued at $24,241,000 after buying an additional 59,200 shares during the period. Finally, Bank of Nova Scotia increased its stake in shares of Inspire Medical Systems by 49.8% during the first quarter. Bank of Nova Scotia now owns 60,000 shares of the company’s stock valued at $3,095,000 after buying an additional 19,958 shares during the period. Hedge funds and other institutional investors own 94.91% of the company’s stock.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.